BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Apr 10, 15:49Prev. Close
169.27
Open Price
186.19
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
175.79 (1)
| Key Financial Ratios of Arvee Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 1.95 | 0.95 | 3.74 | 2.34 | 2.43 | |
| Diluted EPS (Rs.) | 1.95 | 0.95 | 3.74 | 2.34 | 2.43 | |
| Cash EPS (Rs.) | 2.99 | 2.31 | 5.63 | 4.44 | 4.61 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 28.37 | 26.42 | 25.46 | 21.73 | 19.45 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 28.37 | 26.42 | 25.46 | 21.73 | 19.45 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 34.92 | 27.54 | 55.67 | 36.59 | 42.99 | |
| PBDIT/Share (Rs.) | 3.87 | 3.25 | 7.83 | 5.56 | 6.01 | |
| PBIT/Share (Rs.) | 2.83 | 1.89 | 5.95 | 3.46 | 3.83 | |
| PBT/Share (Rs.) | 2.61 | 1.66 | 5.59 | 3.13 | 3.30 | |
| Net Profit/Share (Rs.) | 1.95 | 0.95 | 3.74 | 2.34 | 2.43 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 11.08 | 11.78 | 14.07 | 15.19 | 13.98 | |
| PBIT Margin (%) | 8.10 | 6.85 | 10.68 | 9.44 | 8.90 | |
| PBT Margin (%) | 7.45 | 6.02 | 10.04 | 8.55 | 7.68 | |
| Net Profit Margin (%) | 5.57 | 3.46 | 6.71 | 6.38 | 5.65 | |
| Return on Networth / Equity (%) | 6.86 | 3.61 | 14.67 | 10.75 | 12.48 | |
| Return on Capital Employed (%) | 9.24 | 6.65 | 21.95 | 15.14 | 18.53 | |
| Return on Assets (%) | 5.71 | 2.75 | 10.64 | 6.65 | 6.52 | |
| Total Debt/Equity (X) | 0.03 | 0.03 | 0.04 | 0.13 | 0.41 | |
| Asset Turnover Ratio (%) | 1.02 | 0.79 | 1.59 | 1.01 | 1.27 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 5.14 | 2.42 | 2.44 | 1.75 | 1.40 | |
| Quick Ratio (X) | 3.95 | 1.50 | 1.92 | 1.33 | 0.99 | |
| Inventory Turnover Ratio (X) | 7.03 | 3.08 | 7.48 | 3.53 | 4.18 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 152.60 | 157.16 | 97.08 | 123.80 | 63.32 | |
| EV/Net Operating Revenue (X) | 3.96 | 5.18 | 1.58 | 3.07 | 1.34 | |
| EV/EBITDA (X) | 35.75 | 43.93 | 11.25 | 20.20 | 9.56 | |
| MarketCap/Net Operating Revenue (X) | 4.07 | 5.21 | 1.58 | 3.11 | 1.29 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 5.01 | 5.43 | 3.46 | 5.23 | 2.85 | |
| Price/Net Operating Revenue | 4.07 | 5.21 | 1.58 | 3.11 | 1.29 | |
| Earnings Yield | 0.01 | 0.01 | 0.04 | 0.02 | 0.04 |
24.11.2025
Arvee Lab Standalone September 2025 Net Sales at Rs 3.45 crore, down 72.45% Y-o-Y
12.05.2025
Arvee Lab Standalone March 2025 Net Sales at Rs 6.45 crore, up 4.99% Y-o-Y
14.08.2024
Arvee Laborator Standalone June 2024 Net Sales at Rs 10.60 crore, up 39.57% Y-o-Y
04.06.2024
Arvee Laborator Standalone March 2024 Net Sales at Rs 6.14 crore, down 51.08% Y-o-Y